Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Imiquimod cream 5% effectively treated generalized discoid lupus erythematosus.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Oral etretinate improved hair length and reduced beading in monilethrix.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

The man's rash, hair loss, and vision issues were due to syphilis, not CMV.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Tofacitinib may effectively treat folliculitis decalvans.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

A protein called MPZL3 in mitochondria slows down hair growth and could be a target for treating hair growth disorders.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

The laser treatment effectively and safely improved melasma in Asian patients.